Long noncoding RNA KB-1980E6.3 promotes breast cancer progression through the PI3K/AKT signalling pathway

被引:7
|
作者
He, Lin [1 ]
Tang, Lingfeng [1 ]
Wang, Rui [2 ]
Liu, Li [1 ]
Zhu, Pengpeng [2 ]
Jiang, Kunwei [1 ]
Tu, Gang [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, 1 You Yi Rd, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Key Lab Lab Med Diagnost, Chinese Minist Educ, Chongqing 400016, Peoples R China
基金
中国国家自然科学基金;
关键词
LncRNA KB-1980E6.3; Breast cancer; PI3K/AKT pathway; Proliferation; Invasion;
D O I
10.1016/j.prp.2022.153891
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This research aims to investigate the effect of lncRNA KB-1980E6.3 on the biological behaviour of breast cancer cells under normoxic conditions and the underlying molecular mechanism. The expression of KB-1980E6.3 in breast cancer tissues and cells was detected by RT-qPCR. The proliferation, migration and invasion of cells were evaluated by CCK-8, colony formation, scratch and Transwell assays; KB-1980E6.3-related xenograft models were established for in vivo studies. The protein expression of PI3K, p-PI3K, AKT and p-AKT was validated by western blotting analysis. The levels of KB-1980E6.3 are significantly upregulated in breast cancer tissues and cells and are related to the poor prognosis. Functional research both in vivo and in vitro revealed that the downregulation of KB-1980E6.3 expression significantly decreased cell proliferation, invasion and migration, while ectopic KB-1980E6.3 expression obviously promoted these biological phenotypes. In terms of the mechanism, KB-1980E6.3 is involved in the activation of the PI3K/AKT signalling pathway. Knockdown of KB-1980E6.3 reduced the expression of the p-PI3K and p-AKT proteins, whereas KB-1980E6.3 overexpression showed the opposite result. The agonist 740Y-P and inhibitor LY294002 reversed the effect of KB-1980E6.3 knockdown and overexpression on the PI3K/AKT pathway in BC cells. KB-1980E6.3 promotes the proliferation, invasion and migration of breast cancer cells by activating PI3K/AKT signalling, which can be used as a potential target for breast cancer therapy.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Long Noncoding RNA PlncRNA-1 Promotes Colorectal Cancer Cell Progression by Regulating the PI3K/Akt Signaling Pathway
    Song, Wei
    Mei, Jia-Zhuan
    Zhang, Mingzhi
    ONCOLOGY RESEARCH, 2018, 26 (02) : 261 - 268
  • [2] The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer
    Abu-Alghayth, Mohammed H.
    Khan, Farhan R.
    Belali, Tareg M.
    Abalkhail, Adil
    Alshaghdali, Khalid
    Nassar, Somia A.
    Almoammar, Nasser Eissa
    Almasoudi, Hassan H.
    Hessien, Khater Balatone G.
    Aldossari, Munirah saad
    Binshaya, Abdulkarim S.
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 255
  • [3] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [4] PI3K/Akt signalling pathway-associated long noncoding RNA signature predicts the prognosis of laryngeal cancer patients
    Nie, Qian
    Cao, Huan
    Yang, Jianwang
    Liu, Tao
    Wang, Baoshan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] PI3K/Akt signalling pathway-associated long noncoding RNA signature predicts the prognosis of laryngeal cancer patients
    Qian Nie
    Huan Cao
    JianWang Yang
    Tao Liu
    Baoshan Wang
    Scientific Reports, 13
  • [6] SLC1A3 promotes gastric cancer progression via the PI3K/AKT signalling pathway
    Xu, Liyi
    Chen, Jiamin
    Jia, Litao
    Chen, Xiao
    Moumin, Faycal Awaleh
    Cai, Jianting
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (24) : 14392 - 14404
  • [7] MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway
    Su, Wei
    Feng, Baijie
    Hu, Lina
    Guo, Xianzhi
    Yu, Minghua
    BMC CANCER, 2022, 22 (01)
  • [8] MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway
    Wei Su
    Baijie Feng
    Lina Hu
    Xianzhi Guo
    Minghua Yu
    BMC Cancer, 22
  • [9] Overexpression of CBX2 in breast cancer promotes tumor progression through the PI3K/AKT signaling pathway
    Zheng, Shipeng
    Lv, Peihua
    Su, Jing
    Miao, Keke
    Xu, Han
    Li, Mengquan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (03): : 1668 - 1682
  • [10] RETRACTION: SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway
    Xu, L.
    Chen, J.
    Jia, L.
    Chen, X.
    Moumin, F. A.
    Cai, J.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (15)